Enhanced therapeutic efficacy for glioblastoma immunotherapy with an oncolytic herpes simplex virus armed with anti-PD-1 antibody and IL-12.

Mol Ther Oncol · 2024 · PMC11053222 · PMID 38681801

Europe PMC DOI

hedged sentence

0.0100

closest p · 0.2× alpha

0.0100

boldest claim

The sentences

highly significantp < 0.01actually significant

Specifically, in the case of A172 and D54 cell lines, the increase was highly significant ( p < 0.01), while for U138 and D458, it was statistically significant ( p < 0.05).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.